Repros Therapeutics, Inc. (RPRX)

[spartex]

<<On 4-5-07, FrontPoint Partners owned 562k shares
and there is no mention of Morgan Stanley.
If they are the one and the same, it means they went
from owning 78k shares to owning 562k shares and down to 0
in a matter of 6 months. If they are not, it still means
they accumulated 562k shares and sold it all in a few months.>>

On April 5, RPRX was priced at 10.49 (close), and a little over a month later it is priced near 13. One would think that FrontPoint may have profited from their purchase of RPRX shares below 10.5, and if they had bought them higher (12.5's) in Jan-Feb they would have sold them by end of March quarter (right, if at a loss?). So one can speculate that they were up 25-30% with their investment and therefore sold as RPRX rose during April and early May. In fact, their sales really didn't have any overhang on RPRX price, as it rose 25%. Fast money in, fast money out. I hope the new buyers are "holders" so we can kick it up a bit more. ;)

http://www.stockta.com/cgi-bin/analysis.pl?symb=RPRX&num1=9&cobrand=&mode=stock

It looks like the buyers of the stock are slowing down the past few weeks and are awaiting endo trial results before buying more aggressively. Would be nice to get endo news before the annual meeting so there is more to talk about.